The serological relationship between viruses producing varicella-like exanthems in several subhuman primates, varicella-zoster virus (VZV) and herpes simplex viruses (HSV) types I and 2, was investigated. All the primate viruses were related to VZV and some to HSV also. These results show that there is a group of varicella viruses, comprising four distinct entities, some of which may be useful for the establishment of an animal model for varicella.
INTRODUCTION
With the possible exception of vervet monkeys (Rivers, I926, I927) it has not proved possible to infect laboratory animals with varicella-zoster virus (VZV) and the absence of an animal model has hampered research on this virus. In I967, Clarkson et al. isolated a herpesvirus from vervet monkeys which had died, exhibiting a papular rash. The disease resembled that of varicella in humans, except that the mortality rate was high. Since then seven other herpesviruses have been isolated from varicella-like exanthems in sub-human primates and these are listed in Table I . These viruses were reviewed by McCarthy & Tosolini (I975) who classified them in a group with VZV primarily on the similarity of the disease patterns but also because they are strongly cell-associated in tissue culture. Five of these viruses have been studied in more detail by Felsenfeld & Schmidt (I977) who found them to be indistinguishable antigenically and also to be antigenically related to VZV.
The present study, which includes chimpanzee herpes virus (CZHV) as well as the five viruses used by Felsenfeld & Schmidt (I977) , compares six isolates with one another and also investigates their antigenic relationships to VZV and to herpes simplex virus types I and z (HSV-I and HSV-z).
METHODS

Viruses.
The simian viruses are shown in Table I . It was not possible to obtain a sample of gorilla herpesvirus. The other viruses were supplied by Professor K. McCarthy as infected monolayers of Vero cells, with the exception of chimpanzee herpesvirus (CZHV), which was received as an infected monolayer of primary human thyroid (PHT) cells. These viruses and VZV (Roy strain) were subsequently propagated in Vero cells, by co-cultivation of infected and non-infected cultures, for the production of complement-fixing (CF) and precipitating antigens and for immunofluorescent (IF) studies. CZHV produced an illdefined c.p.e, in Vero cells, consisting of individual rounded-up cells, sparsely scattered (Ablashi et al. 197I) this method was used here. Cultures of Vero monlayers were pre-treated with I5/~g/ml of DEAE-dextran (Pharmacia), then inoculated with CZHV-infected PHT cells. After three days' incubation small syncytia were noted which gradually enlarged. This syncytial c.p.e. could be maintained through five to nine subcultures in untreated Vero cells before it reverted to the original form. CZHV was therefore maintained by subculture in Vero cells which were treated with DEAE-dextran at every fifth subculture.
Cell-free virus for use in VZV neutralization tests was prepared by ultrasonic disruption of infected PHT or human embryonic lung (HEL) cells as previously described (Harbour & Caunt, I975) . Satisfactory preparations were not obtained with the simian agents and neutralization tests were not performed with these viruses. HSV-I (Dunkley strain) and HSV-2 (strain K359 received from Dr Karen Cook) were grown routinely in Vero cells for antigen and virus production.
Cell cultures. Vero cells were grown in medium [99 supplemented with 5 ~ foetal calf serum. The cultures of MLMV and LVV were infected with a Mycoplasma sp., which was suppressed by the addition of 6o/zg/ml Tylocine (Gibco) and 2oo tzg/ml Kanamycin to the medium. The other cultures were, and remained, free of Mycoplasma contamination.
Sera. Antisera to VZV, HSV-I, patas herpes virus (PHV), Liverpool vervet virus (LVV) and Delta primate centre herpes virus type t (DHV-I) were produced by repeated inoculation of vervet monkeys with viruses propagated in Veto cells grown in pooled vervet monkey serum in order to minimise anti-host cell antibodies (A. E. Caunt & K. M. Cook, unpublished data) . A control serum was produced in the same way using uninfected Veto cells. Antisera to HSV-~ and HSV-2 were produced in rabbits in a manner similar to that of Watson et al. (1966) .
The antiserum produced against MLMV in a patas monkey was not hyperimmune. A suspension of infected Vero cells was used to inoculate the monkey intradermally in nine sites and the animal subsequently developed a mild exanthematous disease, similar to that described by Blakely et al. (I973) . The monkey was bled prior to infection and again 18 days later, when the rash was healing.
Antiserum to CZHV was produced in a guinea-pig. The virus was grown in Vero cells for five subcultures, as described above. The infected cells were removed from the glass by trypsin-EDTA treatment and, after centrifugation, were resuspended in medium I99 o/ pooled normal guinea-pig serum. This suspension was added to semicontaining ~o ~o confluent monolayers of guinea-pig embryo cells grown in pooled guinea-pig serum (GPE/ GPS cells). The infection spread to the surrounding GPE/GPS cells. After three serial subcultures, the syncytial c.p.e, was extensive and the cells were harvested using 0.02 °/o EDTA and resuspended in phosphate buffered saline (PBS) before ultrasonic disruption. After centrifugation, the antigen was mixed with an equal volume of to% (w/v) Arlacel in Drakeol as adjuvant and used to immunize a guinea-pig by repeated fortnightly intramuscular injections.
All sera were stored at -zo °C before use and were tested for specific antibody response by CF tests before being used for serological comparisons of the herpesviruses.
Serological tests. Neutralization tests with VZV were performed as described by Caunt & Shaw (I969) and the residual virus was assayed on Vero monolayers by a plaque titration method (Harbour & Caunt, 1975) . Neutralization tests with HSVI and 2 were performed as described by Ross et al. (I965) and residual virus was titrated on Vero monolayers. In all cases where neutralization tests were done in the presence of complement, the method of Stevens et al. (1968) was used. Complement fixation tests were carried out by the method of Grist et al. (1966) . Immunofluorescent staining was by the indirect method described by Gardner & McQuillin (i974) . Viruses were grown in coverslip cultures of Vero cells. The cells were fixed by two washes in cold acetone and then dried in air. Conjugated anti-species y-globulins were purchased from Wellcome Reagents Ltd and used at the highest dilution giving maximal fluorescence with each serum. The immunofluorescence (IF) titre of each serum against each antigen was taken as the highest dilution giving good fluorescence (Gardner & McQuillin, 1974) . These titres were then used to calculate the specific differentiation coefficients (SPD) of each antigen/antiserum pair by the method of Fraser et al. 0972, I974) . In this method the titre is converted to the index number of the twofold dilution (i.e. 1/IO = I, t/zo = 2, ~/4o = 3 and so on). The SPD is calculated by the formula SPD = (Aa + Bb)-(Ab + Ba) where Aa is the index number of the titre of serum A with its homologous virus a, Bb is the index number of the titre of serum B with its homologous virus b, and Ab and Ba are the heterologous reactions. The SPD tends towards zero when two viruses are closely related and is very high when there is no relationship. Gel precipitation tests were carried out as previously described (Harbour & Caunt, 1975) . Antisera were concentrated by lyophilization of the immunoglobulin fraction and were used at three times the serum concentration. Precipitation antigens were produced by ultrasonic disruption of infected Vero cells, and were concentrated by lyophilization to give approx. 4 × to7 infected cell equivalents per/ml.
RESULTS
Neutralization tests
The results of the neutralization tests are shown in Table 2 . The anti-VZV serum showed no reaction with either type of HSV and neither did the anti-HSV sera neutralize VZV. However, the antisera to DHV-1, MLMV, PHV, LVV and CZHV all showed significant increases in titre to VZV. The lowest rise was in the case of the CZHV antiserum which was produced in a guinea-pig and may not be strictly comparable with the monkey sera. In all cases where a rise in titre occurred, this rise was enhanced in the presence of complement. The control vervet serum produced by immunizing a monkey with uninfected Vero cells had no neutralizing effect on any of the viruses.
Complement fixation tests
The results of CF tests are shown in Table 3 . The anti-VZV serum showed significant rises to all the viruses except HSV-z but the increases to the heterologous viruses were much less than to VZV itself and against MLMV and HSV-I the rise was only from < i/4 to 1/8. The antiserum to DHV-t showed rises in titre to DHV-~, DHV-2, LVV, PHV and MLMV and lower but still significant rises to VZV and HSV-2. No rise in titre to HSV-t was found even though the pre-immune serum contained antibodies. There was also no rise in titre to CZHV. The antisera to PHV and LVV showed significant rises to all the viruses except HSV-~ and HSV-2 where the rise was no greater than that to an uninfected control antigen and the antiserum produced by MLMV infection of a patas monkey showed significant rises to all the viruses except CZHV, HSV-I and HSV-2. The guinea-pig antiserum to CZHV showed rises in titre to VZV, PHV, LVV and MLMV but no rise to either isolate of DHV or to either type of HSV. The vervet antiserum to HSV-I showed significant rises to all the viruses but the increase to the two types of HSV was much greater than that to the other viruses and the rises in titres against DHV and CZHV were only twofold greater than the control. The rabbit anti-HSV-[ serum only showed significant rises to PHV and LVV in addition to those to HSV-J and HSV-2, and the anti-HSV-z serum showed rises against VZV and DHV only twofold greater than the controls but had significant rises to both types of HSV.
lmmunofluorescence tests
All the sera showed high IF activity against the homologous virus as can be seen from Table 4 . The anti-VZV and anti-LVV sera showed rises in IF titre to all the viruses except HSV-I and HSV-2 while the anti-PHV serum showed rises to all the viruses. Anti-MLMV serum showed no reaction with HSV-2 and only a minimal rise to CZHV but had significant rises to all the other viruses. The antiserum to DHV-I showed significant increases in IF titre to all the viruses except CZHV and HSV-I and anti-CZHV showed no rises in titre against DHV-I or DHV-2 or against HSV-I and HSV-2. Anti-HSV-I serum showed increased titres to all viruses except CZHV and antiserum to HSV-2 showed increases to all except CZHV and MLMV.
The results were used to calculate the SPD values shown in Table 5 . These show that there is no close relationship between HSV-~ or 2 and the other viruses or between DHV-l and CZHV. The simian viruses and VZV show varying degrees of relationship, some pairs like LVV and PHV or DHV-I and MLMV being very close.
Gel precipitation tests
Only the vervet hyperimmune sera were used in these tests. The patas monkey (anti-MLMV) and guinea-pig (anti-CZHV) sera did not precipitate and the rabbit sera were not used.
Antiserum to VZV produced five precipitin lines with VZV antigens, two with PHV, Table 3 .
Complement-fixing antibody responses of animals immunized with HSV, VZV and simian herpes viruses
Reciprocal of antibody titre in acute/convalescent sera against PHV  LVV  MLMV  CZHV  HSV-I  HSV-2   VZV  --7  8  7  3  6  17  r4  DHV-I  --~  2  6  o  I3  17  12  PHV  ------1  -2  I  II  9 LVV and MLMV, one with DHV-I, DHV-2 and CZHV and none with HSV-I and HSV-m The pattern is shown in Fig. I (a) . If the precipitin lines are labelled 1 to 5 starting at the serum well, line i is shared with MLMV only, line 2 with CZHV only, line 3 is common to MLMV, DHV-I, DHV-2, PHV and LVV, line 4 is shared with PHV and LVV and line 5 is formed only with VZV. The anti-DHV-i serum precipitated with all the virus antigens except CZHV and VZV and a diagram of the pattern obtained is shown in Fig. [(b) . Two lines were produced with DHV-I, DHV-2, PHV and LVV antigens, which showed reactions of identity in each case. One of these lines also showed identity with the single line of precipitation which was produced with MLMV and HSV-2. A precipitation line also occurred with HSV-I but this was unrelated to any of the other lines.
The antisera to PHV and I VV did not precipitate with VZV, CZHV or HSV-I antigens. Antiserum to PHV produced two lines of precipitate with each of the other antigens (see Fig. I c) . One of these precipitation lines was common to PHV, LVV, MLMV, DHV-1 and DHV-2 antigens and a similar common line was produced by anti-LVV serum (see Fig. I d) although in this case there was partial identity with HSV-2 antigen also. The second line produced by anti-PHV serum and PHV antigen also showed identity with that produced by LVV and MLMV but was not related to a second line produced with this serum by DHV-I, DHV-z and HSV-2. HSV-2 antigen also gave a second line with this serum which was unrelated to any of the others. The anti-LVV serum also produced a second fine of precipitate which was common to LVV and PHV antigens but which was not shared by MLMV which had its own second line with this serum.
The only precipitation with anti-HSV-I serum was with HSV-I and HSV-2 antigens.
DISCUSSION
This study shows that there is a group of varicella-like viruses which not only produce similar disease in various simian hosts but are also antigenically related to VZV. The viruses DHV-I and DHV-2 could not be differentiated in any of the tests used here, although no specific antiserum to DHV-2 was available. It is likely that they are isolates of the same virus, which is the conclusion also reached by Felsenfeld & Schmidt (I977) . In the remainder of this discussion therefore we shall refer to DHV as a single entity.
It was not easy to differentiate between DHV, LVV, PHV and MLMV by the serological tests used. However, no relationship between DHV and CZHV could be demonstrated by any of the same methods and this lack of relationship to CZHV clearly differentiates DHV from LVV, PHV and MLMV which do show such relationships. We were not able with any certainty to differentiate serologically between LVV, PHV and MLMV and it is possible that these three isolates are strains of a single virus, differing in biological characteristics such as the severity of disease caused and the tissue-culture host range. Thus, we think that there are two distinct viruses, DHV and the PHV/LVV/MLMV group which have been isolated from exanthematous diseases of patas monkeys. This is at variance with the opinion of Barahona et al. (1974) who listed all such isolates from patas monkeys as patas monkey herpes virus (PMHV). Felsenfeld & Schmidt (1977) also were unable to distinguish DHV from PHV, LVV or MLMV by neutralization or CF tests but they did not have CZHV in their study. CZHV can be seen to be related to PHV, LVV and MLM as well as to VZV. In gel precipitation tests it shares an antigen with VZV which apparently none of the other viruses possess (Fig. I a) and it does not have the antigen which is shared by all the other simian agents (Fig. i a and b) .
None of the simian viruses or VZV were shown to be related to HSV types I and z by neutralization tests but several minor relationships were revealed using other techniques, suggesting that these viruses share antigens not present on the virus surface. DHV was related to HSV-2 and MLMV to HSV-~, while PHV and LVV were related to both types. The minor relationship of MLMV and HSV-I has already been noted by Blakely et al. (~973) but no other reports of these relationships have appeared. The monkeys used to raise anti-DHV and anti-PHV sera already had some anti-HSV-I antibody. These monkeys had originally been selected on the basis of their lack of antibody to VZV and it can be seen that their titres &neutralizing antibody to HSV-r did not rise in the course of immunization and in the case of the anti-DHV monkey neither did the titre of CF or IF antibody but the anti-PHV monkey showed a rise in IF titre to HSV-I. The cause of the pre-existing HSV-I antibody is not known. Vervet monkeys do not carry Herpesvirus simiae (simian B virus) under natural conditions but they may carry other herpesviruses such as SA8 (Malherbe & Harwin, t963 ) and the pre-existing antibody may indicate previous experience of such an agent but we had no facilities for testing this possibility. It could be argued that the use of I6 vtR 45 D.A. HARBOUR AND A. E. CAUNT animals other than monkeys would reduce the possibility of pre-existing, cross-reacting antibodies but this is not necessarily the case because in selecting a guinea-pig for immunization against CZHV we found that 6 out of 12 animals tested already had CF antibody to the virus and this could not have been the result of laboratory acquired infection. We can only conclude that they had a latent infection with a guinea-pig herpes virus (Cuendet & Bonifas, T975) or that occasionally a common antigen exists between otherwise unrelated agents. The advantage of using monkeys for production of antiserum is the absence of antihost-cell antibody shown throughout.
Thus from this study we conclude that these varicella-like simian viruses represent three distinct entities, that is CZHV, DHV and the PHV/LVV/MLMV group, which have major antigenic similarities to varicella but share only minor components with HSV. This conclusion differs from that of Felsenfeld & Schmidt 0977) who could not distinguish DHV from the PHV group but we agree with these workers that the simian agents have more in common with one another than with varicella.
It has been proposed that LVV (Barahona et al. I974) , DHV (Felsenfeld & Schmidt, 1975) or MLMV (Seibold & Allen, I975) may be suitable for establishing an animal model for human varicella. However, these viruses produce a high fatality rate in contrast to the mild disease of varicella in humans. The disease produced by CZHV in young chimpanzees was mild (McClure & Keeling, 197I) and this virus may be more useful for establishing an animal model. There are no reports of the animal host range of CZHV and a more readily available host may be found by experimentation.
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